Search research articles
Contact Us
Filters
Showing results (21-30 of 1,662) with videos related to
Page
of 167
Sort By:
Current Opinion in Rheumatology
|
May 6, 1998
Update on clinical trials in the rheumatic diseases
D E Furst
British Journal of Rheumatology
|
December 24, 1997
The rational use of methotrexate in rheumatoid arthritis and other rheumatic diseases
D E Furst
The American Journal of Medicine
|
January 11, 2000
Pharmacology and efficacy of cyclooxygenase (COX) inhibitors
D E Furst
Seminars in Arthritis and Rheumatism
|
October 1, 1993
Comparing the strengths and weaknesses of observational and experimental studies using a postmarketing surveillance study as a protypic example
D E Furst
Lupus
|
June 1, 1996
Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases
D E Furst
Seminars in Arthritis and Rheumatism
|
January 2, 2009
The risk of infections with biologic therapies for rheumatoid arthritis
Daniel E Furst
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 17, 2008
Perspectives on the cyclooxygenase-2/ cyclooxygenase-1 hypothesis
D E Furst
Drugs
|
January 1, 1990
Rational use of disease-modifying antirheumatic drugs
D E Furst
Current Opinion in Rheumatology
|
November 25, 2000
Rational therapy in the treatment of systemic sclerosis
D E Furst
Israel Journal of Medical Sciences
|
August 1, 1975
Drug hoarding in a rural community in Israel. Results of a pilot epidemiologic investigation
A L Furst
Page
of 167
Search research articles
Search
Showing results (21-30 of 1,662) with videos related to
Sort By:
Page
of 167
Current Opinion in Rheumatology
|
May 6, 1998
Update on clinical trials in the rheumatic diseases
D E Furst
British Journal of Rheumatology
|
December 24, 1997
The rational use of methotrexate in rheumatoid arthritis and other rheumatic diseases
D E Furst
The American Journal of Medicine
|
January 11, 2000
Pharmacology and efficacy of cyclooxygenase (COX) inhibitors
D E Furst
Seminars in Arthritis and Rheumatism
|
October 1, 1993
Comparing the strengths and weaknesses of observational and experimental studies using a postmarketing surveillance study as a protypic example
D E Furst
Lupus
|
June 1, 1996
Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases
D E Furst
Seminars in Arthritis and Rheumatism
|
January 2, 2009
The risk of infections with biologic therapies for rheumatoid arthritis
Daniel E Furst
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 17, 2008
Perspectives on the cyclooxygenase-2/ cyclooxygenase-1 hypothesis
D E Furst
Drugs
|
January 1, 1990
Rational use of disease-modifying antirheumatic drugs
D E Furst
Current Opinion in Rheumatology
|
November 25, 2000
Rational therapy in the treatment of systemic sclerosis
D E Furst
Israel Journal of Medical Sciences
|
August 1, 1975
Drug hoarding in a rural community in Israel. Results of a pilot epidemiologic investigation
A L Furst
Page
of 167